melanomas
We found ERBB4 mutations in 19% of individuals with melanoma and found mutations in two other kinases (FLT1 and PTK2B) in 10% of individuals with melanomas.
We found ERBB4 mutations in 19% of individuals with <span class="disease" id="19718025-4-52-60">melanoma</span> and found mutations in two other kinases (FLT1 and <span class="gene" id="19718025-4-112-117">PTK2B</span>) in 10% of individuals with <span class="disease" id="19718025-4-146-155">melanomas</span>.